BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Med’s Industry

LumiraDx to Sell Point of Care Technology to Roche

The administrators have signed a definitive agreement to sell certain companies of the LumiraDx group related to LumiraDx’s innovative point of care ...

January 02, 2024 | News

Clover's SCB-219M Shows Positive Phase I Results for Chemotherapy-Induced Thrombocytopenia (CIT) Treatment

--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses t...

December 29, 2023 | News

EpiVax Grants ISPRI Toolkit License to Eisai for Preclinical Immunogenicity Screening

The ISPRI toolkit is a secure web-based platform that allows researchers to rapidly assess the immunogenic risk of biologic candidates. The fu...

December 21, 2023 | News

Clarivate Upbeat on Pulsed-field Ablation Market's Potential Revolution

Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today annou...

December 20, 2023 | News

NUS Researchers in Singapore Innovate Flexible Method for Immune Cell Study

Our body's immune system is a complex network of organs, cells, and proteins that work in synchrony to protect our bodies against infections caused by path...

December 19, 2023 | News

Lunit Secures Acquisition of Volpara: Agreement on Scheme Implementation Established

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its proposal to acquire Volpara Health...

December 15, 2023 | News

Lunit Advances Singapore's Healthcare with AI-Powered Medical Imaging Solution.

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, partners with NTT DATA Singapore to introduce Lu...

December 01, 2023 | News

AWAK Technologies' AI Kidney Disease Prediction Tool Receives FDA Breakthrough Designation

The KDPP model helps to assess the risk of kidney disease progression and initiation of renal replacement therapy (dialysis or transplant), within a period...

November 28, 2023 | News

Lunit's AI-Powered Mammography Analysis Solution Proves Comparable to Radiologists in Breast Cancer Detection

- A large population-based retrospective study in Denmark validates that Lunit INSIGHT MMG's accuracy is on par with tha...

November 27, 2023 | News

XtalPi and EDDC Collaborate on Biomedical Innovation with Robotics and Language Models

Building upon an ongoing collaboration that was initiated in December 2022 to utilize artificial intelligence (AI) and automation to develop targ...

November 22, 2023 | News

Lunit's AI Chest Screening to Deploy in Five Saudi Hospitals

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced an expansion of its services in the&nb...

November 17, 2023 | News

CU Medicine Innovates MOZAICTM Microbiome Tech for Fecal Microbiota Transplants

Clostridioides difficile infection (CDI) is a common hospital-acquired infection worldwide. Recurrence and mortality rates have been reported to be up...

November 17, 2023 | News

Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market

Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced that it has received U.S. Food and Dr...

November 15, 2023 | News

GE Healthcare Validates AI Models for Immunotherapy Patient Response Prediction

New data supports the potential role of Artificial Intelligence (AI) in predicting patients’ response to immunotherapies in advance of their treatm...

November 03, 2023 | News

Stay Connected